Cancer remains a pressing public health issue in the United States. The 2024 projections estimate 2,001,140 new cases and 611,720 deaths.
The incidence rate is 440.5 per 100,000 individuals annually, while the mortality rate is 146 per 100,000. As of January 2022, there were approximately 18.1 million
cancer survivors in the United States. The number is expected to rise to 22.5 million by 2032.
The rising number of cases is attributed to the advancements in early detection and treatment, which underscore the urgent need for comprehensive survivorship care. This is a crucial aspect of cancer management that cannot be overlooked.
Gender and racial disparities persist in cancer outcomes, highlighting the injustice in our healthcare system. Men face a higher mortality rate (173.2 per 100,000) than women (126.4 per 100,000), underscoring the urgent need for equitable care for all.
Among racial groups, non-Hispanic Black men have the highest mortality rate at 208.3 per 100,000, while non-Hispanic Asian/Pacific Islander women have the lowest at 82.6 per 100,000.
In 2024, a concerning 14,910 children and adolescents (ages 0 to 19) are expected to be diagnosed with cancer, with 1,590 projected deaths.
These figures underscore the critical and urgent need for advancements in pediatric oncology research and less invasive treatment options.
The most common cancers in 2024 will include breast, prostate, lung, colorectal, melanoma, bladder, kidney, pancreatic, and liver cancers.
Prostate, lung, and colorectal cancers will account for 48% of new cases in men, while breast, lung, and colorectal cancers will make up 51% of new cases in women.
The lifetime risk of developing cancer in the US is approximately 40.5%, underscoring the importance of prevention, regular screenings, and lifestyle changes. These powerful tools can significantly reduce the risk of cancer and empower individuals to take control of their health.
Cancer care costs are rising, reaching $208.9 billion in 2020. With an aging population and the adoption of costly treatments, expenses are projected to climb further, posing challenges to affordable care access.
The 2024 statistics call for urgent action. Reducing cancer incidence and mortality will depend on continued research, education, equitable treatment access, and robust public health initiatives.